Heerlen, NL, 12 Jun 2020 08:15 CEST

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has completed the repurchase of 1.4 million of its own shares at an average price of €98.40. This repurchase covers commitments under share-based compensation plans and shares for stock dividend, in accordance with the announcement on March 2, 2020. The consideration of this repurchase was €137.8 million.

In addition, as a prudent measure given the current Covid-19 environment and given the acquisition of Erber Group announced today, DSM has decided to cancel the remainder of its €1 billion share buy-back program. The €1 billion share buy-back program was first announced on February 14, 2019, with the intention to reduce DSM's issued share capital. Under this program, DSM repurchased 5.4 million shares for a total consideration of €600 million in 2019 and DSM repurchased another 1.3 million shares for a total consideration of €145 million in 2020, bringing the total number of shares repurchased to around 6.6 million shares for a total consideration of €745 million.

For more detailed information see 'Daily transaction details Share Repurchase Program announced 2 March 2020 '. and 'Daily transaction details Share Repurchase Program announced 14 March 2019'.

Attachments

  • Original document
  • Permalink

Disclaimer

Koninklijke DSM NV published this content on 12 June 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 June 2020 06:27:03 UTC